NCT01392716View on ClinicalTrials.gov

A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 1997

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG

rituximab [MabThera/Rituxan]

375 mg/m2 intravenously once a week for 4 weeks

Trial Locations (16)

25030

Besançon

33076

Bordeaux

37044

Tours

44093

Nantes

49033

Angers

54511

Vandœuvre-lès-Nancy

69373

Lyon

69495

Pierre-Bénite

72015

Le Mans

75475

Paris

75571

Paris

76038

Rouen

86021

Poitiers

92141

Clamart

94010

Créteil

06202

Nice

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY